Real-world experience of HIV/TB co-infected patients treated with rifampicin-based TB therapy in combination with dolutegravir-based regimen.
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Dolutegravir (Primary) ; Rifampicin (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 02 Jan 2017 New trial record